Access and Non-Access Site Bleeding after Percutaneous Coronary Intervention and Risk of Subsequent Mortality and Major Adverse Cardiovascular Events

Circulation: Cardiovascular Interventions

Volumn 8, Issue 4, 2015, Pages

  Kwok, Chun Shing ^a   Khan, Muhammad A ^c   Rao, Sunil V ^d   Kinnaird, Tim ^e   Sperrin, Matt ^a,b   Buchan, Iain ^a,b   De Belder, Mark A ^f   Ludman, Peter F ^g   Nolan, James ^h   Loke, Yoon K ⁱ   Mamas, Mamas A ^a,c  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

^c MANCHESTER UNIVERSITY NHS FOUNDATION TRUST   (United Kingdom)

^d DUKE CLINICAL RESEARCH INSTITUTE   (United States)

^e UNIVERSITY HOSPITAL OF WALES   (United Kingdom)

^f JAMES COOK UNIVERSITY HOSPITAL   (United Kingdom)

^g QUEEN ELIZABETH HOSPITAL   (United Kingdom)

^h UNIVERSITY HOSPITALS OF NORTH MIDLANDS NHS TRUST   (United Kingdom)

ⁱ UNIVERSITY OF EAST ANGLIA   (United Kingdom)

Author keywords

cardiovascular disease; hemorrhage; percutaneous coronary intervention

Indexed keywords

ANTICOAGULANT AGENT;

ADVERSE OUTCOME; ANTICOAGULANT THERAPY; ARTICLE; BLEEDING; BRAIN HEMORRHAGE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; CORONARY ARTERY PERFORATION; DISEASE SEVERITY; EMBASE; FEMORAL ARTERY; FEMORAL BLEEDING; FOLLOW UP; GASTROINTESTINAL HEMORRHAGE; HEART TAMPONADE; HEMOPERICARDIUM; HUMAN; MEDLINE; META ANALYSIS; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; PROGNOSIS; RADIAL ARTERY; RANDOMIZED CONTROLLED TRIAL (TOPIC); RETROPERITONEAL HEMORRHAGE; RISK REDUCTION; SENSITIVITY ANALYSIS; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; SYSTEMATIC REVIEW; VASCULAR ACCESS; MORTALITY; POSTOPERATIVE HEMORRHAGE; RISK; SURVIVAL ANALYSIS;

HUMANS; PERCUTANEOUS CORONARY INTERVENTION; POSTOPERATIVE HEMORRHAGE; RISK; SURVIVAL ANALYSIS;

EID: 84935447903     PISSN: 19417640     EISSN: 19417632     Source Type: Journal    
DOI: 10.1161/CIRCINTERVENTIONS.114.001645     Document Type: Article

References (43)

1. Kwok CS, Roa SV, Myint PK, Keavney B, Nolan J, Ludman PF, de Belder MA, Loke YK, Mamas MA. Major bleeding after percutaneous coronary intervention and risk of subsequent mortality: a systematic review and meta-analysis. Open Heart. 2014;1:e000021. Doi: 10. 1136/ openhrt-2013-000021.
2. Chhatriwalla AK, Amin AP, Kennedy KF, House JA, Cohen DJ, Rao SV, Messenger JC, Marso SP; National Cardiovascular Data Registry. Association between bleeding events and in-hospital mortality after percutaneous coronary intervention. JAMA. 2013;309:1022-1029. Doi:101001/jama. 2013. 1556
3. Mehran R, Rao SV, Bhatt DL, Gibson CM, Caixeta A, Eikelboom J, Kaul S, Wiviott SD, Menon V, Nikolsky E, Serebruany V, Valgimigli M, Vranckx P, Taggart D, Sabik JF, Cutlip DE, Krucoff MW, Ohman EM, Steg PG, White H. Standardized bleeding definitions for cardiovascular clinical trials: a consensus report from the Bleeding Academic Research Consortium. Circulation. 2011;123:2736-2747. Doi: 10. 1161/ CIRCULATIONAHA. 110. 009449.
4. Verheugt FW, Steinhubl SR, Hamon M, Darius H, Steg PG, Valgimigli M, Marso SP, Rao SV, Gershlick AH, Lincoff AM, Mehran R, Stone GW. Incidence, prognostic impact, and influence of antithrombotic therapy on access and nonaccess site bleeding in percutaneous coronary intervention. JACC Cardiovasc Interv. 2011;4:191-197. Doi: 10. 1016/ j. jcin. 2010. 10. 011.
5. Vranckx P, Campo G, Anselmi M, Bolognese L, Colangelo S, Biondi-Zoccai G, Moreno R, Piva T, Favero L, Prati F, Nazzaro M, Díaz Fernández JF, Ferrari R, Valgimigli M; Multicenter Evaluation of Single High-Dose Bolus Tirofiban vs. Abciximab with Sirolimus-Eluting Stent or Bare Metal Stent in Acute Myocardial Infarction Study. Does the site of bleeding matter A stratified analysis on location of TIMI-graded bleedings and their impact on 12-month outcome in patients with ST-segment elevation myocardial infarction. EuroIntervention. 2012;8:71-78. Doi: 10. 4244/EIJV8I1A12.
6. Ndrepepa G, Neumann FJ, Richardt G, Schulz S, Tölg R, Stoyanov KM, Gick M, Ibrahim T, Fiedler KA, Berger PB, Laugwitz KL, Kastrati A. Prognostic value of access and non-access sites bleeding after percutaneous coronary intervention. Circ Cardiovasc Interv. 2013;6:354-361. Doi: 10. 1161/CIRCINTERVENTIONS. 113. 000433.
7. Vavalle JP, Clare R, Chiswell K, Rao SV, Petersen JL, Kleiman NS, Mahaffey KW, Wang TY. Prognostic significance of bleeding location and severity among patients with acute coronary syndromes. JACC Cardiovasc Interv. 2013;6:709-717. Doi: 10. 1016/j. jcin. 2013. 03. 010.
8. Doyle BJ, Ting HH, Bell MR, Lennon RJ, Mathew V, Singh M, Holmes DR, Rihal CS. Major femoral bleeding complications after percutaneous coronary intervention: incidence, predictors, and impact on long-term survival among 17, 901 patients treated at the Mayo Clinic from 1994 to 2005. JACC Cardiovasc Interv. 2008;1:202-209. Doi: 10. 1016/j. jcin. 2007. 12. 006.
9. Ellis SG, Bhatt D, Kapadia S, Lee D, Yen M, Whitlow PL. Correlates and outcomes of retroperitoneal hemorrhage complicating percutaneous coronary intervention. Catheter Cardiovasc Interv. 2006;67:541-545. Doi: 10. 1002/ccd. 20671.
10. Pres D, Gasior M, Hawranek M, Gierlotka M, Lekston A, Tajstra M, Piegza J, Wojnar R, Kurek A, Polonski L. Gastrointestinal bleeding after percutaneous coronary intervention determines higher in-hospital and 3-year mortality in patients with ST-segment elevation myocardial infarction. Eur Heart J. 2010;31:354-355.
11. Farouque HM, Tremmel JA, Raissi Shabari F, Aggarwal M, Fearon WF, Ng MK, Rezaee M, Yeung AC, Lee DP. Risk factors for the development of retroperitoneal hematoma after percutaneous coronary intervention in the era of glycoprotein IIb/IIIa inhibitors and vascular closure devices. J Am Coll Cardiol. 2005;45:363-368. Doi: 10. 1016/j. jacc. 2004. 10. 042.
12. Ioannidis JP, Trikalinos TA. The appropriateness of asymmetry tests for publication bias in meta-analyses: a large survey. CMAJ. 2007;176:1091-1096. Doi: 10. 1503/cmaj. 060410.
13. Davies HT, Crombie IK, Tavakoli M. When can odds ratios mislead? BMJ. 1998;316:989-991.
14. Abbas AE, Brodie B, Dixon S, Marsalese D, Brewington S, O'Neill WW, Grines LL, Grines CL. Incidence and prognostic impact of gastrointestinal bleeding after percutaneous coronary intervention for acute myocardial infarction. Am J Cardiol. 2005;96:173-176. Doi: 10. 1016/j. Amjcard. 2005. 03. 038.
15. Amabile N, Jacquier A, Shuhab A, Gaudart J, Bartoli JM, Paganelli F, Moulin G. Incidence, predictors, and prognostic value of intramyocardial hemorrhage lesions in ST elevation myocardial infarction. Catheter Cardiovasc Interv. 2012;79:1101-1108. Doi: 10. 1002/ccd. 23278.
16. Chin MW, Yong G, Bulsara MK, Rankin J, Forbes GM. Predictive and protective factors associated with upper gastrointestinal bleeding after percutaneous coronary intervention: a case-control study. Am J Gastroenterol. 2007;102:2411-2416. Doi: 10. 1111/j. 1572-0241. 2007. 01460. x.
17. Chua SK, Liao CS, Hung HF, Cheng JJ, Chiu CZ, Chang CM, Lee SH, Lin SC, Liou JY, Lo HM, Kuan P, Shyu KG. Gastrointestinal bleeding and outcomes after percutaneous coronary intervention for ST-segment elevation myocardial infarction. Am J Crit Care. 2011;20:218-225. Doi: 104037/ajcc2011683.
18. Ergelen M, Uyarel H, Soylu O, Ayhan E, Ciçek G, Akyüz S, Yildirim A, Nurkalem Z, Tezel T. Gastrointestinal bleeding in patients undergoing primary angioplasty for acute myocardial infarction: incidence, risk factors and prognosis. Turk Kardiyol Dern Ars. 2010;38:101-106.
19. Gaglia MA Jr, Torguson R, Gonzalez MA, Ben-Dor I, Maluenda G, Collins SD, Syed AI, Delhaye C, Wakabayashi K, Belle L, Mahmoudi M, Hanna N, Xue Z, Kaneshige K, Suddath WO, Kent KM, Satler LF, Pichard AD, Waksman R. Correlates and consequences of gastrointestinal bleeding complicating percutaneous coronary intervention. Am J Cardiol. 2010;106:1069-1074. Doi: 10. 1016/j. Amjcard. 2010. 06. 011.
20. Matic D MD, Asanin M, Stankovic S, Mrdovic I, Antonijevic N, Marjanovic M, Zivkovic I, Vukcevic V, Stankovic G. Impact of access and nonaccess site bleeding measured by Bleeding Academic Research Consortium (BARC) criteria on long-term outcome in patients treated with primary percutaneous coronary intervention. Eur Heart J. 2013;34(suppl 1):218.
21. Nikolsky E, Stone GW, Kirtane AJ, Dangas GD, Lansky AJ, McLaurin B, Lincoff AM, Feit F, Moses JW, Fahy M, Manoukian SV, White HD, Ohman EM, Bertrand ME, Cox DA, Mehran R. Gastrointestinal bleeding in patients with acute coronary syndromes: incidence, predictors, and clinical implications: analysis from the ACUITY (Acute Catheterization and Urgent Intervention Triage Strategy) trial. J Am Coll Cardiol. 2009;54:1293-1302. Doi: 10. 1016/j. jacc. 2009. 07. 019.
22. Shivaraju A, Patel V, Fonarow GC, Xie H, Shroff AR, Vidovich MI. Temporal trends in gastrointestinal bleeding associated with percutaneous coronary intervention: analysis of the 1998-2006 Nationwide Inpatient Sample (NIS) database. Am Heart J. 2011;162:1062-1068. e5.
23. Song XT, Lü SZ, Chen YD, Yuan F, Lin Y, Tian R, Chen X, Jin ZN, Zhou Y, Ge CJ, Meng K, Liu H. Incidence of in-hospital upper gastrointestinal haemorrhage post percutaneous coronary interventions in the drug eluting stent era: a single center experience. Zhonghua Xin Xue Guan Bing Za Zhi. 2007;35:308-311.
24. Stathopoulos I, Kossidas K, Panagopoulos G, Garratt K. Cardiac tamponade complicating coronary perforation during angioplasty: short-term outcomes and long-term survival. J Invasive Cardiol. 2013;25:486-491.
25. Thiele H, Kubusch K, Fuermau G, De Waha S, Desch S, Schuler G, Eitel I. Prognostic value of intramyocardial haemorrhage detected by cardiac magnetic resonance imaging in acute reperfused ST-elevation myocardial infarction. Eur Heart J. 2010;31:1107.
26. Trimarchi S, Smith DE, Share D, Jani SM, O'Donnell M, McNamara R, Riba A, Kline-Rogers E, Gurm HS, Moscucci M; BMC2 Registry. Retroperitoneal hematoma after percutaneous coronary intervention: prevalence, risk factors, management, outcomes, and predictors of mortality: a report from the BMC2 (Blue Cross Blue Shield of Michigan Cardiovascular Consortium) registry. JACC Cardiovasc Interv. 2010;3:845-850. Doi: 10. 1016/j. jcin. 2010. 05. 013.
27. White HD, Aylward PE, Gallo R, Bode C, Steg G, Steinhubl SR, Montalescot G; STEEPLE Investigators. Hematomas of at least 5 cm and outcomes in patients undergoing elective percutaneous coronary intervention: insights from the SafeTy and Efficacy of Enoxaparin in PCI patients, an internationaL randomized Evaluation (STEEPLE) trial. Am Heart J. 2010;159:110-116. Doi: 10. 1016/j. Ahj. 2009. 10. 034.
28. Yatskar L, Selzer F, Feit F, Cohen HA, Jacobs AK, Williams DO, Slater J. Access site hematoma requiring blood transfusion predicts mortality in patients undergoing percutaneous coronary intervention: datafrom the National Heart, Lung, and Blood Institute Dynamic Registry. Catheter Cardiovasc Interv. 2007;69:961-966. Doi: 10. 1002/ccd. 21087.
29. Yeh JL, Wu B. Impact of gastrointestinal hemorrhage in patients receiving percutaneous coronary stents for acute myocardial infarction in the United States. Gastrointest Endosc. 2013;77:AB217.
30. Rao SV, Ou FS, Wang TY, Roe MT, Brindis R, Rumsfeld JS, Peterson ED. Trends in the prevalence and outcomes of radial and femoral approaches to percutaneous coronary intervention: a report from the National Cardiovascular Data Registry. JACC Cardiovasc Interv. 2008;1:379-386. Doi: 10. 1016/j. jcin. 2008. 05. 007.
31. Romagnoli E, Biondi-Zoccai G, Sciahbasi A, Politi L, Rigattieri S, Pendenza G, Summaria F, Patrizi R, Borghi A, Di Russo C, Moretti C, Agostoni P, Loschiavo P, Lioy E, Sheiban I, Sangiorgi G. Radial versus femoral randomized investigation in ST-segment elevation acute coronary syndrome: the RIFLE-STEACS (Radial Versus Femoral Randomized Investigation in ST-Elevation Acute Coronary Syndrome) study. J Am Coll Cardiol. 2012;60:2481-2489. Doi: 10. 1016/j. jacc. 2012. 06. 017.
32. Mamas MA, Ratib K, Routledge H, Neyses L, Fraser DG, de Belder M, Ludman PF, Nolan J; British Cardiovascular Intervention Society and the National Institute for Cardiovascular Outcomes Research. Influence of arterial access site selection on outcomes in primary percutaneous coronary intervention: are the results of randomized trials achievable in clinical practice? JACC Cardiovasc Interv. 2013;6:698-706. Doi: 10. 1016/ j. jcin. 2013. 03. 011.
33. Bertrand OF, Bélisle P, Joyal D, Costerousse O, Rao SV, Jolly SS, Meerkin D, Joseph L. Comparison of transradial and femoral approaches for percutaneous coronary interventions: a systematic review and hierarchical Bayesian metaanalysis. Am Heart J. 2012;163:632-648. Doi: 10. 1016/j. Ahj. 2012. 01. 015.
34. Mamas MA, Anderson SG, Carr M, Ratib K, Buchan I, Sirker A, Fraser DG, Hildick-Smith D, de Belder M, Ludman PF, Nolan J; British Cardiovascular Intervention Society; National Institute for Cardiovascular Outcomes Research. Baseline bleeding risk and arterial access site practice in relation to procedural outcomes after percutaneous coronary intervention. J Am Coll Cardiol. 2014;64:1554-1564. Doi: 10. 1016/j. jacc. 2014. 05. 075.
35. Chase AJ, Fretz EB, Warburton WP, Klinke WP, Carere RG, Pi D, Berry B, Hilton JD. Association of the arterial access site at angioplasty with transfusion and mortality: the M. O. R. T. A. L study (Mortality benefit Of Reduced Transfusion after percutaneous coronary intervention via the Arm or Leg). Heart. 2008;94:1019-1025. Doi: 10. 1136/hrt. 2007. 136390.
36. Ratib K, Mamas MA, Routledge HC, Ludman PF, Fraser D, Nolan J. Influence of access site choice on incidence of neurologic complications after percutaneous coronary intervention. Am Heart J. 2013;165:317-324. Doi: 10. 1016/j. Ahj. 2012. 10. 015.
37. Feldman DN, Swaminathan RV, Kaltenbach LA, Baklanov DV, Kim LK, Wong SC, Minutello RM, Messenger JC, Moussa I, Garratt KN, Piana RN, Hillegass WB, Cohen MG, Gilchrist IC, Rao SV. Adoption of radial access and comparison of outcomes to femoral access in percutaneous coronary intervention: an updated report from the national cardiovascular data registry (2007-2012). Circulation. 2013;127:2295-2306. Doi: 10. 1161/CIRCULATIONAHA. 112. 000536.
38. Baklanov DV, Kaltenbach LA, Marso SP, Subherwal SS, Feldman DN, Garratt KN, Curtis JP, Messenger JC, Rao SV. The prevalence and outcomes of transradial percutaneous coronary intervention for ST-segment elevation myocardial infarction: analysis from the National Cardiovascular Data Registry (2007 to 2011). J Am Coll Cardiol. 2013;61:420-426. Doi: 10. 1016/j. jacc. 2012. 10. 032.
39. Wiviott SD, Braunwald E, McCabe CH, Montalescot G, Ruzyllo W, Gottlieb S, Neumann FJ, Ardissino D, De Servi S, Murphy SA, Riesmeyer J, Weerakkody G, Gibson CM, Antman EM; TRITON-TIMI 38 Investigators. Prasugrel versus clopidogrel in patients with acute coronary syndromes. N Engl J Med. 2007;357:2001-2015. Doi: 10. 1056/ NEJMoa0706482.
40. Wallentin L, Becker RC, Budaj A, Cannon CP, Emanuelsson H, Held C, Horrow J, Husted S, James S, Katus H, Mahaffey KW, Scirica BM, Skene A, Steg PG, Storey RF, Harrington RA, Freij A, Thorsén M; PLATO Investigators. Ticagrelor versus clopidogrel in patients with acute coronary syndromes. N Engl J Med. 2009;361:1045-1057. Doi: 10. 1056/ NEJMoa0904327.
41. Zeymer U, van 't Hof A, Adgey J, Nibbe L, Clemmensen P, Cavallini C, ten Berg J, Coste P, Huber K, Deliargyris EN, Day J, Bernstein D, Goldstein P, Hamm C, Steg PG. Bivalirudin is superior to heparins alone with bailout GP IIb/IIIa inhibitors in patients with ST-segment elevation myocardial infarction transported emergently for primary percutaneous coronary intervention: a pre-specified analysis from the EUROMAX trial. Eur Heart J. 2014;35:2460-2467. Doi: 10. 1093/eurheartj/ehu214.
42. Stone GW, Witzenbichler B, Guagliumi G, Peruga JZ, Brodie BR, Dudek D, Kornowski R, Hartmann F, Gersh BJ, Pocock SJ, Dangas G, Wong SC, Kirtane AJ, Parise H, Mehran R; HORIZONS-AMI Trial Investigators. Bivalirudin during primary PCI in acute myocardial infarction. N Engl J Med. 2008;358:2218-2230. Doi: 10. 1056/NEJMoa0708191.
43. Subherwal S, Peterson ED, Dai D, Thomas L, Messenger JC, Xian Y, Brindis RG, Feldman DN, Senter S, Klein LW, Marso SP, Roe MT, Rao SV. Temporal trends in and factors associated with bleeding complications among patients undergoing percutaneous coronary intervention: a report from the National Cardiovascular Data CathPCI Registry. J Am Coll Cardiol. 2012;59:1861-1869. Doi: 10. 1016/j. jacc. 2011. 12. 045.